The expression of HDAC5 and lysine-specific demethylase 1 (LSD1) was elevated in breast cancer, and HDAC5 enhanced the LSD1 protein stability and reduced the nuclear level of H3K4me1/me2 in breast cancer cells (50). This evidence concerns the gene HDAC5 and breast carcinoma.